Skip to search formSkip to main contentSkip to account menu

CR 1409

Known as: CR-1409 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Availability of specific cholecystokinin (CCK) receptor antagonists has the potential for contributing to delineation of the role… 
Highly Cited
1990
Highly Cited
1990
Cholecystokinin (CCK) has been shown to promote pancreatic growth and azaserine-induced pancreatic carcinogenesis in rats. The… 
1988
1988
The inhibitory effect of CR-1409, a new glutaramic acid derivative and a competitive inhibitor for cholecystokinin (CCK), on the… 
1987
1987
The effects of a new glutaramic acid derivative, 3,4-dichloro-benzamido-N, N-dipentyl-glutaramic acid (CR-1409), on…